CLU and Alzheimer disease: Published data have mainly focused on the cholesterol efflux capacity (CEC) of CSF HDL and showed that it is reduced in AD patients [13, 14]; a very recent report has suggested that the CSF levels of apoJ are a determinant of the low CSF CEC observed in dementia [15].